Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Evaluation of Tirzepatide in Adults With Alcohol Use Disorder and Overweight or Obesity

NCT06994338 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT06994338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06994338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Evaluation of Tirzepatide in Adults With Alcohol Use Disorder and Overweight or Obesity
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Recruiting
Start date
October 6, 2025
Completion date
August 31, 2026
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol, alcohol use disorder, obesity and overweight